Attend the breakfast on April 4 at MassBio - "Core Components for Contamination Prevention & Control in Biopharma Manufacturing Operations" with Gary du Moulin
Learn more about the biotech expansion occurring in California and how Massachusetts' life sciences is spurring this growth. What's on the horizon for 2017?
How can pharmaceutical companies handle out of specification (OOS) results related to manufacturing? Read our blog post to determine the steps you need to take.
For pharmaceutical companies, appropriate preparation for pre-approval inspections (PAI) is critical. Learn which subject matter experts need to be involved.